Regardless of the cell type, the researchers found that damage to the mitochondria did not cause cell death. This observation ...
Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback